Purpose: Two ophthalmic solutions of 0.3% ciprofloxacin eye drops are avail
able in Turkey: Ciloxan and Siprogut. A previous study by the same authors
was the first to report vitreous penetration of ciprofloxacin-containing ey
e drops. The aim of the present study was to compare the levels of drug fou
nd in the subretinal fluid by the two products following local administrati
on.
Methods: Forty-three patients undergoing conventional retinal detachment su
rgery received either Ciloxan (22 patients) or Siprogut (21 patients). Begi
nning 6 h before surgery, two drops of solution were instilled onto the ope
rative eye every 30 min for the first 3 h and then hourly for the next 3 h.
Subretinal fluid samples were collected 30 min after administration of the
last dose and were assayed for ciprofloxacin levels using a method involvi
ng high- performance liquid chromatography with fluorometric detection.
Results: The minimum and maximum subretinal fluid concentrations measured w
ere 0.11 mug/mL and 0.65 mug/mL, respectively, with Ciloxan, and 0.08 mug/m
L and 0.62 mug/mL, respectively, with Siprogut. There was no statistical di
fference between the subretinal fluid ciprofloxacin levels of the two produ
cts. The subretinal fluid drug levels attained by both products were below
the minimum inhibitory concentrations of common ocular pathogens.
Conclusions: Ciloxan and Siprogut can penetrate subretinal fluid. The ocula
r bioavailability of ciprofloxacin after local administration is equivalent
for both pharmaceutical products.